Liberty TripAdvisor (LTRPA, LTRPB) Skyrockets 2,000%
Liberty TripAdvisor (LTRPA, LTRPB) skyrockets 2,000% in four hours. This could of been the result of the investment they secured last month.
Liberty TripAdvisor (LTRPA, LTRPB) skyrockets 2,000% in four hours. This could of been the result of the investment they secured last month.
Aytu Bioscience (AYTU) is up big another 6% in pre market hours on the premise of positive COVID-19 sales according to a recent press release.
Today FDA government officials has approved these two companies Cytosorbents (CTSO) and SCWorx (WORX) on blood purification and testing for the coronavirus. SCWorx (WORX) SCWorx
For the past 5 years iBio ($IBIO) stock has been on a gradual decline in stock price. The lastest run up from $0.30 to $2.50
Seanergy ($SHIP) operates as an international shipping company specializing in the worldwide seaborne transportation of dry bulk commodities. It focuses on owning and management of
Sonnet BioTherapeutics (SONN) has candidates in immunomodulatory therapies, their first-wave pipeline comprises five cytokine-derived candidates, with lead compound, SON-080, ready to enter Phase 2 development,
The reason you cannot find the stock is because Chanticleer Holdings ($BURG) has now become Sonnet BioTherapeutics ($SONN) through a reverse merger according to the
Chanticleer Holdings (now Amergent Hospitality Group (AMHG)) owns and operates franchises in the fast casual and full service restaurant industry. Coronavirus is out and people
A small little known company called Aytu Bioscience develops rapid point of care 2-10 minute test kits for the 2019 novel coronavirus which has been
iBio ($IBIO) may be a risky investment after a 10% decline in stock price, investors are now questioning their investment. Year to date iBio has
Stockpence is currently seeking to expand our team of contributors. We’re looking for financial gurus & article writers to write about trending market news and investment ideas about the stock market.
If you’re interested please contact us!
Investing involves substantial risk. Neither the authors, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the articles herein. No reader should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, on any featured company here.
Some of the companies featured here may pay a fee to an affiliate of the publication to broaden awareness of said company.
The principals of the publication may buy or sell shares of the featured companies from time-to-time.
Join our free mailing list below to receive real-time news alerts and our next featured stock!
Investing involves substantial risk. Neither the Authors, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the articles herein. No reader should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, on any featured company here.
Some of the companies featured here may pay a fee to an affiliate of the publication to broaden awareness of said company.
The principals of the publication may buy or sell shares of the featured companies from time-to-time.
Join our free mailing list below to receive real-time news alerts and our next featured stock!